LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article: Triple terapia 10 días con esomeprazol 40 mg/12 h vs. cuádruple concomitante sin bismuto como tratamiento de primera línea de la infección por Helicobacter pylori.

    Campillo, Ana / Amorena, Edurne / Ostiz, Miriam / Kutz, Marcos / LaIglesia, Matilde

    Gastroenterologia y hepatologia

    2016  Volume 39, Issue 9, Page(s) 584–589

    Abstract: Introduction: Quadruple concomitant non-bismuth therapy has recently become the most widely prescribed first-line treatment for Helicobacter pylori infection in Spain. Whether optimized conventional triple therapy can achieve comparable efficacy rates ... ...

    Title translation 10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection.
    Abstract Introduction: Quadruple concomitant non-bismuth therapy has recently become the most widely prescribed first-line treatment for Helicobacter pylori infection in Spain. Whether optimized conventional triple therapy can achieve comparable efficacy rates remains to be seen.
    Material and methods: Retrospective study comparing the efficacy of triple and quadruple concomitant therapy, and sub-analysis following administration of both for 10 days with esomeprazole 40mg/12h.
    Results: A first-line therapy was administered to 657 patients from 1st January 2012 to 31st December 2014. Quadruple therapy (n=371) showed higher efficacy than triple therapy (n=248) for both intention-to-treat (85.9% vs. 65.7%; P<.001) and per protocol analysis (92.5% vs. 68.4%; P<.001). When both therapies included esomeprazole 40mg/12h administered for 10 days, quadruple concomitant therapy (n=108) also had higher efficacy than triple therapy (n=76) for intention-to-treat (90.7% vs. 73.6%; P=.003) and per protocol analysis (92.5% vs.74.6%; P=.002).
    Conclusions: Quadruple concomitant therapy with high dose proton pump inhibitor (PPI) for 10 days achieves a significantly higher eradication outcome than optimized triple therapy, with rates of over 90% when the PPI prescribed is esomeprazole 40mg/12h.
    Language Spanish
    Publishing date 2016-11
    Publishing country Spain
    Document type Journal Article ; English Abstract
    ZDB-ID 632502-6
    ISSN 0210-5705
    ISSN 0210-5705
    DOI 10.1016/j.gastrohep.2016.03.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Comparación de cuádruple terapia concomitante sin bismuto con triple terapia clásica como primera línea de tratamiento para la erradicación del Helicobacter pylori.

    Campillo, Ana / Ostiz, Miriam / Amorena, Edurne / Kutz, Marcos / La Iglesia, Matilde

    Medicina clinica

    2016  Volume 147, Issue 5, Page(s) 199–201

    Abstract: Background and objective: In a previous study we found that the classical triple therapy for Helicobacter pylori (H. pylori) had low efficacy (under 70%) in our area. After this finding, in mid 2012 quadruple concomitant therapy started to be prescribed ...

    Title translation Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection.
    Abstract Background and objective: In a previous study we found that the classical triple therapy for Helicobacter pylori (H. pylori) had low efficacy (under 70%) in our area. After this finding, in mid 2012 quadruple concomitant therapy started to be prescribed in our hospital. The aim of the present study is to compare the efficacy of classical triple therapy and quadruple concomitant therapy without bismuth.
    Material and methods: Observational retrospective study of prescribed treatments between 1st January 2012 and 5th May 2014 and their efficacy.
    Results: During the study period 510 patients were prescribed a first line therapy; in 179 cases (35,1%) the combination amoxiciline+clarithromicine+PPI was prescribed during 7-14 days, and 298 patients (58,4%) were treated with amoxicillin+clarithromycin+metronidazole+PPI for 10 days. The quadruple concomitant therapy had a higher efficacy than the classical triple therapy, both in an "intention to treat" (84.8% vs. 65.7%, P=.001) and "per protocol" (86.9% vs. 67.2%, P=.001) analysis. Triple therapy had a higher efficacy when it was prescribed for 10 days compared to 7 days (77.9% vs. 56.5%, P=.005 per "intention to treat" and 77.9% vs. 58.5%, P=.011 "per protocol"). When quadruple concomitant therapy was compared with classical triple therapy prescribed over 10 days no significant differences were found.
    Conclusions: In our setting, cuadruple concomitant therapy without bismuth has a high efficacy as first line therapy for H. pylori eradication, with much better results than classical triple therapy in the way that it is most widely prescribed (short courses of 7-day with a single dose of omeprazole).
    Language Spanish
    Publishing date 2016-09-02
    Publishing country Spain
    Document type English Abstract ; Journal Article
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2016.05.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Endoscopic submucosal dissection in Spain: outcomes and development possibilities.

    Vila, Juan J / Kutz, Marcos / Fernández-Esparrach, Gloria / López-Rosés, Leopoldo / Rodríguez, Sarbelio / Sánchez-Yague, Andres

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva

    2013  Volume 105, Issue 9, Page(s) 544–552

    Abstract: Endoscopic submucosal dissection (ESD) allows endoscopic, curative, en-bloc resection of superficial malignant or premalignant lesions. This procedure was conceived over 10 years ago in Japan, but has not experienced great expansion in Western countries ... ...

    Abstract Endoscopic submucosal dissection (ESD) allows endoscopic, curative, en-bloc resection of superficial malignant or premalignant lesions. This procedure was conceived over 10 years ago in Japan, but has not experienced great expansion in Western countries for different reasons. This article reviews ESD indications and outcomes, and reflects on the reasons that prevent ESD from becoming common clinical practice in Western hospitals. Finally, recommendations on ESD training in our setting are made.
    MeSH term(s) Diffusion of Innovation ; Endoscopy, Gastrointestinal/methods ; Endoscopy, Gastrointestinal/statistics & numerical data ; Gastric Mucosa/surgery ; Humans ; Spain ; Stomach Neoplasms/surgery ; Treatment Outcome
    Language English
    Publishing date 2013-03-04
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 1070381-0
    ISSN 1130-0108 ; 0212-7512
    ISSN 1130-0108 ; 0212-7512
    DOI 10.4321/s1130-01082013000900006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Ectopia tiroidea retroperitoneal.

    Kutz, Marcos / Vila, Juan José / Urman, Jesús María / Garaigorta, Maitane / Guinduláin, Eva / Tarifa, Antonio / Gómez, María Luisa

    Gastroenterologia y hepatologia

    2012  Volume 35, Issue 6, Page(s) 400–403

    Abstract: The presence of subdiaphragmatic thyroid tissue is a very rare finding. We reviewed the literature and found only 15 published cases. The most appropriate management of this entity has not been established, but surgical removal is common to exclude ... ...

    Title translation Ectopic retroperitoneal thyroid gland.
    Abstract The presence of subdiaphragmatic thyroid tissue is a very rare finding. We reviewed the literature and found only 15 published cases. The most appropriate management of this entity has not been established, but surgical removal is common to exclude malignancy. We present the case of a 76-year-old woman with an ectopic mesenteric thyroid gland forming a retroperitoneal mass that was surgically removed. Outcome was favorable.
    MeSH term(s) Aged ; Biopsy, Fine-Needle ; Choristoma/diagnostic imaging ; Choristoma/pathology ; Choristoma/surgery ; Female ; Humans ; Retroperitoneal Space ; Thyroid Gland ; Tomography, X-Ray Computed ; Ultrasonography, Interventional
    Language Spanish
    Publishing date 2012-06
    Publishing country Spain
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 632502-6
    ISSN 0210-5705
    ISSN 0210-5705
    DOI 10.1016/j.gastrohep.2012.03.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Endoscopic and anesthetic feasibility of EUS and ERCP combined in a single session versus two different sessions.

    Vila, Juan J / Kutz, Marcos / Goñi, Silvia / Ostiz, Miriam / Amorena, Edurne / Prieto, Carlos / Rodriguez, Cristina / Fernández-Urien, Ignacio / Jiménez, Francisco J

    World journal of gastrointestinal endoscopy

    2011  Volume 3, Issue 3, Page(s) 57–61

    Abstract: Aim: To discuss the feasibility of single session endoscopic ultrasonography (EUS) to discuss and endoscopic retrograde cholangiopancreatography (ERCP) execution.: Methods: Retrospective endoscopic and anesthetic outcome comparison of performing both ...

    Abstract Aim: To discuss the feasibility of single session endoscopic ultrasonography (EUS) to discuss and endoscopic retrograde cholangiopancreatography (ERCP) execution.
    Methods: Retrospective endoscopic and anesthetic outcome comparison of performing both EUS and ERCP in a single endoscopic session (Group I) versus performing each procedure in two different sessions (Group II) was made. The following variables were evaluated: epidemiological variables, American Society of Anesthesiologists Physical Status Classification (ASA) level, procedural time, propofol dose, anesthetic complications, endoscopic complications and diagnostic yield, and therapeutic procedures on both groups. T-student, Chi-Square and Fisher test were used for comparison.
    Results: We included 39 patients in Group I (mean age: 69.85 ± 9.25; 27 men) and 46 in Group II (mean age: 67.46 ± 12.57; 25 men). Procedural time did not differ significantly between both groups (Group Ivs Group II: 93 ± 32.78 vs 98.98 ± 38.17; P >0.05) but the dose of propofol differed (Group I vs Group II: 322.28 ± 250.54 mg vs 516.96 ± 289.06 mg; P = 0.001). Three patients had normal findings on both explorations. Three anesthetic complications [O(2) desaturation (2), broncoaspiration (1)] and 9 endoscopic complications [pancreatitis (6), bleeding (1), perforation (1), cholangitis (1)] occurred without significant differences between both groups (P > 0.05). We did not find any significant difference regarding age, sex, ASA scale level, diagnostic yield or therapeutic maneuvers between both groups.
    Conclusion: The performance of EUS and ERCP in a single session offers a similar diagnostic and therapeutic yield, does not entail a higher complication risk and requires a significantly smaller dose of propofol for sedation compared with performing each exploration in a different session.
    Language English
    Publishing date 2011-03-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2573698-X
    ISSN 1948-5190 ; 1948-5190
    ISSN (online) 1948-5190
    ISSN 1948-5190
    DOI 10.4253/wjge.v3.i3.57
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.

    Chaparro, María / Garre, Ana / Núñez Ortiz, Andrea / Diz-Lois Palomares, María Teresa / Rodríguez, Cristina / Riestra, Sabino / Vela, Milagros / Benítez, José Manuel / Fernández Salgado, Estela / Sánchez Rodríguez, Eugenia / Hernández, Vicent / Ferreiro-Iglesias, Rocío / Ponferrada Díaz, Ángel / Barrio, Jesús / Huguet, José María / Sicilia, Beatriz / Martín-Arranz, María Dolores / Calvet, Xavier / Ginard, Daniel /
    Alonso-Abreu, Inmaculada / Fernández-Salazar, Luis / Varela Trastoy, Pilar / Rivero, Montserrat / Vera-Mendoza, Isabel / Vega, Pablo / Navarro, Pablo / Sierra, Mónica / Cabriada, José Luis / Aguas, Mariam / Vicente, Raquel / Navarro-Llavat, Mercè / Echarri, Ana / Gomollón, Fernando / Guerra Del Río, Elena / Piñero, Concepción / Casanova, María José / Spicakova, Katerina / Ortiz de Zarate, Jone / Torrella Cortés, Emilio / Gutiérrez, Ana / Alonso-Galán, Horacio / Hernández-Martínez, Álvaro / Marrero, José Miguel / Lorente Poyatos, Rufo / Calafat, Margalida / Martí Romero, Lidia / Robledo, Pilar / Bosch, Orencio / Jiménez, Nuria / Esteve Comas, María / Duque, José María / Fuentes Coronel, Ana María / Josefa Sampedro, Manuela / Sesé Abizanda, Eva / Herreros Martínez, Belén / Pozzati, Liliana / Fernández Rosáenz, Hipólito / Crespo Suarez, Belén / López Serrano, Pilar / Lucendo, Alfredo J / Muñoz Vicente, Margarita / Bermejo, Fernando / Ramírez Palanca, José Joaquín / Menacho, Margarita / Carmona, Amalia / Camargo, Raquel / Torra Alsina, Sandra / Maroto, Nuria / Nerín de la Puerta, Juan / Castro, Elena / Marín-Jiménez, Ignacio / Botella, Belén / Sapiña, Amparo / Cruz, Noelia / Forcelledo, José Luis F / Bouhmidi, Abdel / Castaño-Milla, Carlos / Opio, Verónica / Nicolás, Isabel / Kutz, Marcos / Abraldes Bechiarelli, Alfredo / Gordillo, Jordi / Ber, Yolanda / Torres Domínguez, Yolanda / Novella Durán, María Teresa / Rodríguez Mondéjar, Silvia / Martínez-Cerezo, Francisco J / Kolle, Lilyan / Sabat, Miriam / Ledezma, Cesar / Iyo, Eduardo / Roncero, Óscar / Irisarri, Rebeca / Lluis, Laia / Blázquez Gómez, Isabel / Zapata, Eva María / José Alcalá, María / Martínez Pascual, Cristina / Montealegre, María / Mata, Laura / Monrobel, Ana / Hernández Camba, Alejandro / Hernández, Luis / Tejada, María / Mir, Alberto / Galve, María Luisa / Soler, Marta / Hervías, Daniel / Gómez-Valero, José Antonio / Barreiro-de Acosta, Manuel / Rodríguez-Artalejo, Fernando / García-Esquinas, Esther / Gisbert, Javier P / On Behalf Of The EpidemIBD Study Group Of Geteccu

    Journal of clinical medicine

    2022  Volume 11, Issue 19

    Abstract: The authors wish to make the following corrections to this paper [ ... ]. ...

    Abstract The authors wish to make the following corrections to this paper [...].
    Language English
    Publishing date 2022-09-30
    Publishing country Switzerland
    Document type Published Erratum
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11195816
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.

    Chaparro, María / Garre, Ana / Núñez Ortiz, Andrea / Diz-Lois Palomares, María Teresa / Rodríguez, Cristina / Riestra, Sabino / Vela, Milagros / Benítez, José Manuel / Fernández Salgado, Estela / Sánchez Rodríguez, Eugenia / Hernández, Vicent / Ferreiro-Iglesias, Rocío / Ponferrada Díaz, Ángel / Barrio, Jesús / Huguet, José María / Sicilia, Beatriz / Martín-Arranz, María Dolores / Calvet, Xavier / Ginard, Daniel /
    Alonso-Abreu, Inmaculada / Fernández-Salazar, Luis / Varela Trastoy, Pilar / Rivero, Montserrat / Vera-Mendoza, Isabel / Vega, Pablo / Navarro, Pablo / Sierra, Mónica / Cabriada, José Luis / Aguas, Mariam / Vicente, Raquel / Navarro-Llavat, Mercè / Echarri, Ana / Gomollón, Fernando / Guerra Del Río, Elena / Piñero, Concepción / Casanova, María José / Spicakova, Katerina / Ortiz de Zarate, Jone / Torrella Cortés, Emilio / Gutiérrez, Ana / Alonso-Galán, Horacio / Hernández-Martínez, Álvaro / Marrero, José Miguel / Lorente Poyatos, Rufo / Calafat, Margalida / Martí Romero, Lidia / Robledo, Pilar / Bosch, Orencio / Jiménez, Nuria / Esteve Comas, María / Duque, José María / Fuentes Coronel, Ana María / Josefa Sampedro, Manuela / Sesé Abizanda, Eva / Herreros Martínez, Belén / Pozzati, Liliana / Fernández Rosáenz, Hipólito / Crespo Suarez, Belén / López Serrano, Pilar / Lucendo, Alfredo J / Muñoz Vicente, Margarita / Bermejo, Fernando / Ramírez Palanca, José Joaquín / Menacho, Margarita / Carmona, Amalia / Camargo, Raquel / Torra Alsina, Sandra / Maroto, Nuria / Nerín de la Puerta, Juan / Castro, Elena / Marín-Jiménez, Ignacio / Botella, Belén / Sapiña, Amparo / Cruz, Noelia / Forcelledo, José Luis F / Bouhmidi, Abdel / Castaño-Milla, Carlos / Opio, Verónica / Nicolás, Isabel / Kutz, Marcos / Abraldes Bechiarelli, Alfredo / Gordillo, Jordi / Ber, Yolanda / Torres Domínguez, Yolanda / Novella Durán, María Teresa / Rodríguez Mondéjar, Silvia / Martínez-Cerezo, Francisco J / Kolle, Lilyan / Sabat, Miriam / Ledezma, Cesar / Iyo, Eduardo / Roncero, Óscar / Irisarri, Rebeca / Lluis, Laia / Blázquez Gómez, Isabel / Zapata, Eva María / José Alcalá, María / Martínez Pascual, Cristina / Montealegre, María / Mata, Laura / Monrobel, Ana / Hernández Camba, Alejandro / Hernández, Luis / Tejada, María / Mir, Alberto / Galve, María Luisa / Soler, Marta / Hervías, Daniel / Gómez-Valero, José Antonio / Barreiro-de Acosta, Manuel / Rodríguez-Artalejo, Fernando / García-Esquinas, Esther / Gisbert, Javier P

    Journal of clinical medicine

    2021  Volume 10, Issue 13

    Abstract: 1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: ... ...

    Abstract (1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and 0.5 for IBD-U; 53% of patients were male and median age was 43 years (interquartile range = 31-56 years). During a median 12-month follow-up, 34% of patients were treated with systemic steroids, 25% with immunomodulators, 15% with biologics and 5.6% underwent surgery. The percentage of patients under these treatments was significantly higher in CD than UC and IBD-U. Use of systemic steroids and biologics was significantly higher in hospitals with high resources. In total, 28% of patients were hospitalized (35% CD and 22% UC patients,
    Language English
    Publishing date 2021-06-29
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm10132885
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top